PRTN3 and vasculitis: With the confirmed anti-PR3 c-ANCA and the initial improvement on IV steroids, the diagnosis of vasculitis became the likeliest explanation for the patient's symptoms, including the lung lesion, now cavitating, and the symmetrical lesions in the brain.